Pharmacy Leadership Certificate: Beyond the Basics for Advancing Managers
ACPE Numbers: Various - see below
Release Date: August 20, 2025
Expiration Date: August 20, 2028
Activity Type: Application-based
CE Contact Hour(s): 19.5 contact hours
Overview
The Pharmacy Leadership Certificate: Beyond the Basics for Advancing Managers is a self-guided, online learning activity that has been developed for pharmacists and pharmacy technicians in entry- to mid-level leadership positions who desire to expand their knowledge about a variety of pharmacy management topics. The curriculum of this certificate is based on the High-Value Pharmacy Enterprise (HVPE) Framework and includes presentations relevant to each of the HVPE domains:
- Patient Care Services
- Business Services
- Ambulatory and Specialty Pharmacy Services
- Inpatient Operations
- Safety and Quality
- Pharmacy Workforce
- Information Technology, Data, and Information Management
- Leadership
Pharmacy Leadership Certificate: Beyond the Basics for Advancing Managers Requirement
Once a learner has completed the educational curriculum, they will have the opportunity to complete an online comprehensive exam. Once the learner completes the exam (minimum 80% passing rate; unlimited attempts permitted), they will earn the professional certificate.
Accreditation
![]() |
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation. |
Target Audience
This professional certificate has been developed for pharmacists and pharmacy technicians in entry- to mid-level leadership positions who desire to expand their knowledge about a variety of pharmacy management topics related to the High-Value Pharmacy Enterprise (HVPE) Framework.
Learning Objectives
Patient Care Services
ACPE: 0204-0000-25-818-H04-P&T
Application-based
3.25 contact hours
Learning Objectives:
- Describe the critical role of health system pharmacy team involvement in transitions of care (TOC) and the impact of pharmacy TOC interventions on patient outcomes.
- Explain barriers to safe and effective care during patient transitions and the importance of collaboration in improving patient care across the care continuum.
- Explain fundamental concepts and goals of antibiotic stewardship programs.
- Identify effective strategies and best practices for implementing antibiotic stewardship programs in both inpatient and outpatient settings.
- Discuss the importance of fostering collaboration among healthcare professionals to enhance the success of antibiotic stewardship initiatives.
- Select relevant metrics and data to assess the effectiveness of antibiotic stewardship interventions and enable quality improvement.
- Describe care models that improve the safety and quality of anticoagulation for hospitalized patients.
- Identify key criteria and resources for the implementation of pharmacogenomic services.
- Evaluate the qualities of available options for performing pharmacogenomic testing and the factors involved in the translation and delivery of results.
Ambulatory and Specialty Pharmacy Services
ACPE: 0204-0000-25-819-H04-P&T
Application-based
1.50 contact hours
Learning Objectives:
- Compare and contrast specialty pharmacy services with traditional retail pharmacy services.
- Explain the differences between biologics and biosimilars versus brand and generic name medications.
- Differentiate among the three types of procurement models for sourcing medications administered in a healthcare setting, i.e., white-, brown-, and clear-bagging.
- Select the appropriate billing methods for specialty medications.
- Explain population health concepts.
- Summarize incentives for health systems to provide population health services.
- Describe the role of pharmacists in the provision of population health services.
- Describe opportunities for antithrombotic stewardship in the ambulatory care setting.
Business Services
ACPE: 0204-0000-25-820-H04-P&T
Application-based
2 contact hours
Learning Objectives:
- Predict return on investment (ROI) for patient care pharmacy services.
- Differentiate between direct and indirect pharmacy revenue.
- Compare patient care and business cases for pharmacy services.
- Explain budget line items to consider when planning pharmacy services.
- Identify areas of improvement in budgets that are being reviewed by management.
- Select meaningful metrics to track the health of the pharmacy business.
- Describe the role of population health services in managing healthcare costs.
- Analyze models of value-based care reimbursement.
- Identify pharmacy strategies to drive cost savings and improve health outcomes.
Inpatient Operations
ACPE: 0204-0000-25-821-H04-P&T
Application-based
3.25 contact hours
Learning Objectives:
- Describe pharmacy technician product verification (TPV) including the opportunities and limitations of pharmacy technician roles, regulations regarding TPV, and the impact of TPV on pharmacy operations.
- Define "drug diversion."
- Interpret the Drug Enforcement Administration (DEA) Code of Federal Regulations (CFR) as it relates to controlled substances processes.
- Summarize the process for investigating incidents of drug diversion.
- Explain the key characteristics of intravenous workflow management systems (IV-WMS).
- Describe the benefits and challenges of implementing IV-WMS and strategies for continuous improvement of this technology.
Safety and Quality
ACPE: 0204-0000-25-822-H05-P&T
Application-based
4 contact hours
Learning Objectives:
- Explain the fundamental principles and concepts characteristic of high reliability organizations.
- Describe how high-reliability practices drive safe and effective care in the complex medication use system.
- Use external resources to prospectively evaluate medication safety risks.
- Identify the components of failure mode and effects analysis (FMEA).
- Explain the strengths and limitations of proactive risk identification, such as FMEA.
- Explain the major steps and components of a root cause analysis (RCA) process.
- Compare alternative methodologies available for conducting cause analyses.
- Identify regulatory expectations for event management to protect patients, improve systems, and prevent harm.
- Identify quality measures (QMs) applicable to the pharmacy department.
- Prioritize QMs for the pharmacy department.
- Develop a plan to integrate the pharmacy department's QMs into the organization-wide quality improvement program and engage key stakeholders.
Pharmacy Workforce
ACPE: 0204-0000-25-823-H04-P&T
Application-based
1.5 contact hours
Learning Objectives:
- Describe the current hospital pharmacy technician and pharmacist workforce environment.
- Develop effective strategies for staff recruitment and improving engagement and retention.
- Describe career advancement pathways for the pharmacy workforce including, but not limited to; justifying the financial investment in career pathways; and objective criteria for eligibility, selection, and sustained competency.
- Summarize the evolution of pharmacy technician roles.
- Describe non-traditional and advanced roles for pharmacy technicians.
- Explain strategies for implementation of advanced roles into career pathways for pharmacy technicians.
Information Technology, Data, and Information Management
ACPE: 0204-0000-25-824-H04-P&T
Application-based
2.75 contact hours
Learning Objectives:
- Describe the growing area of health information technology and U.S. federal initiatives.
- Discuss various roles of individuals in pharmacy informatics.
- List key technologies used across the medication-use spectrum.
- Identify success factors that can improve performance in pharmacy informatics.
- Identify the principles of medication safety risk identification.
- Compare strengths and limitations of methods of reactive medication safety risk identification.
- Compare automated dispensing cabinet (ADC) modalities, locations, and impact on medication use.
- Evaluate ADC configurations that support safe medication use processes.
Leadership
ACPE: 0204-0000-25-825-H04-P&T
Application-based
1.25 contact hours
Learning Objectives:
- Differentiate between "managers" and "leaders."
- Describe examples of traditional and contemporary leadership styles and apply the optimal style to a given scenario.
- Explain the concept of "evidence-based management."
- Describe what is meant by “managing up,” and why and how pharmacy leaders should use managing up skills.
- Evaluate a pharmacy department’s current scope of services to identify opportunities for new and/or expanded services.
- Identify the most significant barriers to implementing new and/or expanded pharmacy services and strategies for addressing these barriers.
- Describe an effective approach to presenting proposals for new and/or expanded pharmacy services to C-suite leadership.
Course Modules
Learning Activity |
ACPE Number |
Contact Hours |
Patient Care Services |
0204-0000-25-818-H04-P/T |
3.25 |
Ambulatory and Specialty Pharmacy Services |
0204-0000-25-819-H04-P/T |
1.50 |
Business Services |
0204-0000-25-820-H04-P/T |
2.0 |
Inpatient Operations |
0204-0000-25-821-H04-P/T |
3.25 |
Safety and Quality |
0204-0000-25-822-H04-P/T |
4.0 |
Pharmacy Workforce |
0204-0000-25-823-H04-P/T |
1.5 |
Information Technology, Data, and Information Management |
0204-0000-25-824-H04-P/T |
2.75 |
Leadership |
0204-0000-25-825-H04-P/T |
1.25 |
→ Final Assessment: 80% passing score required |
Faculty
Amisha Arya, PharmD, BCSCP, CJCP, FASHP
System Director of Pharmacy Regulatory and Compliance
NYU Langone Health
New York, New York
Matthew Bertsch, PharmD, 340B, ACE, CPEL
Director of Pharmacy/Education
Sun Life Health
Casa Grande, Arizona
Kelly Besco, PharmD, FISMP, CPPS
Advisor, High Reliability Organization (HRO)
OhioHealth
Columbus, Ohio
James Besier, PhD, MS, BS Pharm, CPEL, FASHP
Adjunct Associate Professor
University of Cincinnati
James L. Winkle College of Pharmacy
Cincinnati, Ohio
Jeff Brock, PharmD, MBA, BCIDP
Infectious Diseases Pharmacy Specialist
MercyOne Medical Center
Des Moines, Iowa
Joshua Coffield, PharmD, MBA, CPEL
President - Professional Member
Delaware Board of Pharmacy
Clinical Staff Pharmacist
ChristianaCare Health System
Wilmington, Delaware
William Dager, PharmD, BCPS, MCCM, FASHP, FACCP, FCSHP
Acute and Critical Care Pharmacist Specialist (retired)
UC Davis Medical Center
California
Marisol De Leon, PharmD, MBA, CPEL
Director of Pharmacy Operations
University of Maryland Medical Center
Baltimore, Maryland
Patrick Ford, PharmD, MMHC, BCPS
Pharmacy Program Director
Vanderbilt University Medical Center
Nashville, Tennessee
Leigh Fritz, PharmD, MS, CPEL
Pharmacy Director
Atrium Health Wake Forest Baptist
High Point, North Carolina
Dana Harman, PharmD, MBA, CSP
Specialty Pharmacy Manager
University of Missouri Health Care
Columbia, Missouri
Maybeth James, PharmD, MS
Pharmacy Manager, Transitions of Care and Value Based Care
Cleveland Clinic
Cleveland, Ohio
Kellie Knight, PharmD, MBA, BCPS, DPLA, CPEL
Director of Pharmacy and Clinical Dietitians
IU Health South Region
Bloomington, Indiana
Danielle Neal, PharmD, MBA, BCPS, CHC, CPEL
Associate Vice President of Compliance - Pharmacy
Advocate Health
Charlotte, North Carolina
Jenny Nguyen, PharmD, APh, BCPS
Clinical Pharmacogenomics Specialist
Children’s Hospital Los Angeles
Los Angeles, California
Adjunct Faculty
Massachusetts College of Pharmacy and Health Sciences
Boston, Massachusetts
Brandon Ordway, PharmD, MS
Director of Pharmacy
M Health Fairview
Minneapolis, Minnesota
Elizabeth Rebo, PharmD, MBA, CPPS
Executive Director, Pharmacy Quality & Medication Safety
Kaiser Permanente
Los Angeles, California
Anne Rose, PharmD
Manager, Acute Care Services
University of Wisconsin Hospital and Clinics - UW Health
Madison, Wisconsin
Andrew Stivers, PharmD
Director - Medication Safety, Quality, and Regulatory
Dana-Farber Cancer Institute
Boston, Massachusetts
Dyson Wake, PharmD, BCPS
Senior Clinical Specialist, Pharmacogenomics
Residency Program Director, PGY2 Clinical Pharmacogenetics
Mark R. Neaman Center for Personalized Medicine
Endeavor Health
Evanston, Illinois
Kayla Waldron, PharmD, MS, BCPS, FASHP
Director, Medication Use and Quality Improvement
American Society of Health-Systems Pharmacists
Bethesda, Maryland
Relevant Financial Relationship Disclosure
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
- No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company.
Methods and CE Requirements
Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Important Note – ACPE 60 Day Deadline: Per ACPE requirements, CPE credit must be claimed within 60 days of being earned – no exceptions! To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, we encourage you to check your NABP eProfile account to validate your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.